36 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Medications: ... Agent, Initiation ... Dose and Max Dosages ... #Pharmacology # ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... Non-Opioid Analgesics - Agents ... #Pharmacology # ... NonOpioid #Analgesics #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... Muscle Relaxants - Agents ... #Pharmacology # ... Relaxers #Relaxants #Medications ... #Doses #Dosing
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... Distribution, Agents ... #Pharmacology # ... Nerve #Blocks #Medications ... #Doses #Dosing
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... getting patients on medication ... both of these medications ... to the target dose ... HeartFailure #HFrEF #Pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
be considered (doses ... Disease Note: Treatment ... PO in 2 divided doses ... #opportunistic ... infections #HIVAIDS #pharmacology
Neurological Side Effects of Antipsychotic Drugs
Acute dystonia - Spasm of muscles of tongue, face, neck, back
• Tx: Reduce dose ... greatest risk • Tx: Dose ... reduction; change medication ... months or years of treatment ... #SideEffects #pharmacology
A summary of the pharmacologic management of acute bleeding and secondary prevention of bleeds in LVAD
summary of the pharmacologic ... Anti-secretory Agents ... LVAD #Bleeding #Pharmacology ... #Management #Treatment ... #Medications #Secondary
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
- ACR/VF 2021 Guidelines ... Therapy; high-dose ... immunosuppressive agent ... Vasculitis #Management #Treatment ... #ACR2021 #Guidelines
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... - Agents and Dosing ... #Management #Pain ... #Pharmacology # ... #Doses #Dosing